Hydralazine Hydrochloride Tablet
Product Images NDC 43353-124

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 43353-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 100mg (43353 0124 05)

Packaging label for Hydralazine HCl 100 mg oral tablets, containing 4200 tablets. The label includes storage instructions and indicates the product is repackaged by Aphena Pharma Solutions - Tennessee, LLC, with original manufacturer listed as TEVA Czech Industries s.r.o., Czech Republic. The label also displays multiple barcodes and the prescription-only designation.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chem Structure (F1bb5be7 E8b0 4dd1 Be95 Afac3d59c460 01)

Chemical structure of Hydralazine Hydrochloride showing the arrangement of nitrogen and carbon atoms in the bicyclic compound with hydrazine functional group and associated hydrochloride (HCl).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.